Abstract
The inflammatory bowel diseases, both ulcerative colitis and Crohn’s disease, have been suggested as significant risk factors for adenocarcinoma of the colon and small bowel. Professional guidelines have addressed endoscopic surveillance of the colon in patients with colitis [Farraye et al. (Gastroenterology 138(2):746–74, 2010); Winawer et al. (Gastroenterology 124(2):544–60, 2003); Kornbluth and Sachar (Am J Gastroenterol 105:501–23, 2010); Leighton et al. (Gastrointest Endosc 63(4):558–65, 2006); Eaden et al. (Gut 51 Suppl 5:V10, 2002); Cairns et al. (Gut ;59(5):666–89, 2010); Hanauer and Meyers (Am J Gastroenterol 92(4):559–66, 1997); Colorectal cancer surveillance in inflammatory bowel disease, UpToDate. Updated 2013.], but post-proctocolectomy surveillance of the ileal pouch has been specifically addressed by only a few [Cairns et al. (Gut ;59(5):666–89, 2010); Colorectal cancer surveillance in inflammatory bowel disease, UpToDate. Updated 2013]. These guidelines advocate stratifying surveillance of the ileal pouch according to risk group. Pouch dysplasia or cancer is infrequent but elevated over what would be expected [Ziv et al. (Dis Colon Rectum 37(12):1281–5, 1994); Scarpa (Br J Surg 94:534–45, 2007); Kariv (Gastroenterology 139(3):806–12, 2010); Derikx et al. (Gastroenterology 146(1):119–28, 2014)]. High-risk groups are those considered to have previous rectal dysplasia, dysplasia or cancer at time of pouch surgery, primary sclerosing cholangitis (PSC), or Type C mucosa of the pouch (persistent atrophy and severe inflammation). However, recent large cohort studies have shown that the risk of neoplasia of the pouch is increased only in patients who had colorectal neoplasia (dysplasia or cancer) prior to surgery [Ziv et al. (Dis Colon Rectum 37(12):1281–5, 1994); Scarpa (Br J Surg 94:534–45, 2007); Kariv (Gastroenterology 139(3):806–12, 2010); Derikx et al. (Gastroenterology 146(1):119–28, 2014)]. No specific protocol is currently recommended for pouch surveillance endoscopy by professional societies. In this chapter we will review in detail the relevant literature regarding prevalence of pouch neoplasia, surveillance indications, suggested protocols for pouch surveillance, and suggested management of pouch-associated dysplasia or cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138(2):746–74.
Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence Gastrointestinal Consortium Panel. Gastroenterology. 2003;124(2):544–60.
Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501–23.
Leighton JA, Shen B, Baron TH, Adler DG, Davila R, Egan JV, Faigel DO, Gan SI, Hirota WK, Lichtenstein D, Qureshi WA, Rajan E, Zuckerman MJ, VanGuilder T, Fanelli RD, Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc. 2006;63(4):558–65.
Eaden JA, Mayberry JF, British Society for Gastroenterology, Association of Coloproctology for Great Britain and Ireland. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut. 2002;51 Suppl 5:V10.
Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, Eaden JA, Rutter MD, Atkin WP, Saunders BP, Lucassen A, Jenkins P, Fairclough PD, Woodhouse CR, British Society of Gastroenterology, Association of Coloproctology for Great Britain and Ireland. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59(5):666–89.
Hanauer SB, Meyers S. Management of Crohn’s disease in adults. Am J Gastroenterol. 1997;92(4):559–66.
Colorectal cancer surveillance in inflammatory bowel disease, UpToDate. Updated 2013.
Ziv Y, Fazio VW, Sirimarco MT, Lavery IC, Goldblum JR, Petras RE. Incidence, risk factors, and treatment of dysplasia in the anal transitional zone after ileal pouch-anal anastomosis. Dis Colon Rectum. 1994;37(12):1281–5.
Scarpa M, van Koperen PJ, Ubbink DT, Hommes DW, Ten Kate FJ, Bemelman WA. Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis. Br J Surg. 2007;94:534–45.
Kariv R, Remzi FH, Lian L, Bennett AE, Kiran RP, Kariv Y, Fazio VW, Lavery IC, Shen B. Preoperative colorectal neoplasia increases risk for pouch neoplasia in patients with restorative proctocolectomy. Gastroenterology. 2010;139(3):806–12.
Derikx LA, Kievit W, Drenth JP, de Jong DJ, Ponsioen CY, Oldenburg B, van der Meulen-de Jong AE, Dijkstra G, Grubben MJ, van Laarhoven CJ, Nagtegaal ID, Hoentjen F; Dutch Initiative on Crohn and Colitis. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease. Gastroenterology. 2014;146(1):119–28.
M’Koma AE, Moses HL, Adunyah SE. Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. Int J Colorectal Dis. 2011;26(5):533–52.
Kariv R, Leshno M, Shen B. A cost effectiveness analysis of surveillance pouch endoscopy for ulcerative colitis patients with ileal pouches. Abstract, DDW 2013.
Anis A, Ahmadi MD, Steven P. Endoscopy/surveillance in inflammatory bowel disease. Surg Clin North Am. 2007;87:743–62.
Zhu H, Wu X-R, Queener E, Kiran RP, Remzi FH, Shen B. Clinical value of surveillance pouchoscopy in asymptomatic ileal pouch patients with underlying inflammatory bowel disease. Surg Endosc. 2013;27:4325–32.
Herline AJ, Meisinger LL, Rusin LC, et al. Is routine pouch surveillance for dysplasia indicated for ileoanal pouches? Dis Colon Rectum. 2003;46:156–9.
Nilubol N, Scherl E, Bub DS, et al. Mucosal dysplasia in ileal pelvic pouches after restorative proctocolectomy. Dis Colon Rectum. 2007;50:825–31.
Liu ZX, Xiao MB, Wu XR, Queener E, Ni RZ, Shen B. Chronic pouchitis is associated with pouch polyp formation in patients with underlying ulcerative colitis. J Crohns Colitis. 2013;8(5):363–9.
Zisman TL, Rubin DT. Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol. 2008;14:2662–9.
Risques RA, Lai LA, Brentnall TA, Li L, Feng Z, Gallaher J, Mandelson MT, Potter JD, Bronner MP, Rabinovitch PS. Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology. 2008;135(2):410–8.
Odze RD. Pathology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol Clin North Am. 2006;35:533–52.
McLaughlin SD, Clark SK, Thomas-Gibson S, Tekkis PP, Ciclitira PJ, Nicholls RJ. Guide to endoscopy of the ileo-anal pouch following restorative proctocolectomy with ileal pouch-anal anastomosis; indications, technique, and management of common findings. Inflamm Bowel Dis. 2009;15:1256–63.
Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis disease activity index. Mayo Clin Proc. 1994;69:409–15.
Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology. 1994;107:1856–60.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Kariv, R., Lashner, B. (2015). Surveillance for Neoplasia in the Patient with an Ileal Pouch. In: Kozarek, R., Chiorean, M., Wallace, M. (eds) Endoscopy in Inflammatory Bowel Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-11077-6_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-11077-6_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11076-9
Online ISBN: 978-3-319-11077-6
eBook Packages: MedicineMedicine (R0)